SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Vaccinex, Inc. to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference on March 19, 2019
[March 13, 2019]

Vaccinex, Inc. to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference on March 19, 2019


ROCHESTER, N.Y., March 13, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and Huntington’s disease, today announced that it will be presenting at Oppenheimer & Co.’s 29th Annual Healthcare Conference on Tuesday, March 19th at 3:55PM ET in Track 2.  Maurice Zauderer, Ph.D., president & CEO, will be presenting an update on the Company’s ongoing clinical development programs and will be available for meetings with investors.

The Oppenheimer & Co. 29th Annua Healthcare Conference will be held March 19-20, 2019 at the Westin New York Grand Central in New York City.  Please contact conference organizers for investor meetings.



About Vaccinex, Inc.
Vaccinex, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders.

Investor Contact


Jeremy Feffer
LifeSci Advisors, LLC
Phone: 212-915-2568
Email: jeremy@lifesciadvisors.com

Media Contact

Jules Abraham
JQA Partners, Inc.
Phone: (917) 885-7378
E-mail: jabraham@jqapartners.com

Vaccinex logo


[ Back To TMCnet.com's Homepage ]









Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2019 Technology Marketing Corporation. All rights reserved | Privacy Policy